New England Research & Management, Inc. Biomarin Pharmaceutical Inc Transaction History

New England Research & Management, Inc.

$213 Million
Q3 2024

A detailed history of New England Research & Management, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, New England Research & Management, Inc. holds 13,625 shares of BMRN stock, worth $864,097. This represents 0.45% of its overall portfolio holdings.

Number of Shares

13,625

Previous 9,075 50.14%

Holding current value

$864,097

Previous $747,000 28.25%

% of portfolio

0.45%

Previous 0.36%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$69.02 - $93.84 $314,041 - $426,972	4,550 Added 50.14%	13,625 $958,000
Q2 2024 Jul 09, 2024	SELL	$74.43 - $92.22 $467,048 - $578,680	-6,275 Reduced 40.88%	9,075 $747,000
Q1 2024 Apr 16, 2024	BUY	$83.81 - $99.0 $1.29 Million - $1.52 Million	15,350 New	15,350 $1.34 Million
Q1 2023 Apr 06, 2023	BUY	$87.74 - $117.27 $837,917 - $1.12 Million	9,550 New	9,550 $929,000
Q2 2022 Jul 20, 2022	SELL	$71.48 - $86.85 $669,267 - $813,176	-9,363 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$74.28 - $92.69 $323,192 - $403,294	4,351 Added 86.81%	9,363 $722,000
Q4 2021 Jan 05, 2022	BUY	$71.72 - $91.47 $359,460 - $458,447	5,012 New	5,012 $443,000
Q1 2021 Apr 16, 2021	SELL	$74.73 - $90.69 $504,427 - $612,157	-6,750 Closed	0 $0
Q4 2020 Jan 07, 2021	BUY	$72.61 - $90.2 $490,117 - $608,850	6,750 New	6,750 $592,000
Q3 2019 Nov 04, 2019	SELL	$67.4 - $85.11 $212,310 - $268,096	-3,150 Closed	0 $0
Q2 2019 Jul 09, 2019	SELL	$80.35 - $93.9 $28,122 - $32,865	-350 Reduced 10.0%	3,150 $270,000
Q1 2019 Apr 03, 2019	BUY	$84.2 - $98.62 $294,700 - $345,170	3,500 New	3,500 $311,000
Q4 2018 Jan 11, 2019	SELL	$80.14 - $106.07 $440,770 - $583,385	-5,500 Closed	0 $0
Q3 2018 Oct 03, 2018	BUY	$93.92 - $105.72 $516,560 - $581,460	5,500 New	5,500 $533,000

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Research & Management, Inc. with notifications on news.

Account

New England Research & Management, Inc. Biomarin Pharmaceutical Inc Transaction History